Amazon ramps up trademarks for pharmacy business

Amy Baxter | | Health Exec | Policy & Regulations
Some patients with certain autoimmune diseases in some states are finding it difficult to obtain their prescriptions for methotrexate as a result of changing abortion care laws.

Amazon is signaling it may soon sell prescription drugs in the U.K., Canada and Australia after the company moved to trademark “Amazon Pharmacy” in those countries at the start of 2020, CNBC reported.

According to trademark filings, Amazon may also move into surgical, medical dental instruments and pharmaceutical.

Amazon has continually increased its presence in the healthcare space, including acquiring online pharmacy PillPack in 2018 for $1 billion. The brand Amazon Pharmacy has begun to appear on printed materials and labels since the end of 2019.

While the trademark filing doesn’t mean Amazon has imminent plans to sell prescription medications, it does indicate the company’s desires to “go global,” CNBC reported.

See the full story below:

Amazon just filed a bunch of international trademarks for ‘Amazon Pharmacy’

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

Report: 44% of adults in the U.S. are uninsured or underinsured
Texas AG sues hospital for $10K after off-duty police barred from carrying guns
Cardiologists reflect on developing primary PCI in face of criticism and pushback
PBMs sue FTC for alleged Fifth Amendment violation
FDA issues Class I alert on Philips ventilators after 4 injuries
Trump selects Emmy-winning TV personality Dr. Oz to head CMS

Around the web

Cardiovascular Business
Q&A: MedAxiom CEO explores key trends in cardiologist, cardiovascular surgeon compensation

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

Cardiovascular Business
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

AI in Healthcare
A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”